Nephertiti Efeovbokhan Data-verified
Affiliation confirmed via AI analysis of OpenAlex, ORCID, and web sources.
Researcher
faculty
Research Areas
Biography and Research Information
OverviewAI-generated summary
Nephertiti Efeovbokhan's research focuses on health outcomes and interventions, particularly concerning cardiovascular health and diabetes management. She has investigated the impact of patient activation and mHealth technology on HbA1c and cardiovascular risk in patients with diabetes mellitus as part of the Office Guidelines Applied to Practice - IMPACT Program. Additionally, her work includes a review of the pathophysiology and management modalities of diabetic foot ulcers. Efeovbokhan has also examined same-day discharge protocols for structural heart disease interventions in the context of the COVID-19 pandemic. Her research includes a retrospective study on shared decision-making scores and their association with blood pressure control within the Office-GAP IMPACT Program. Efeovbokhan holds a 6 h-index with 19 publications and 245 citations.
Metrics
- h-index: 6
- Publications: 19
- Citations: 258
Selected Publications
-
Abstract P332: High Shared Decision-Making Scores Associated with Blood Pressure Control: The Office Guidelines Applied to Practice (Office-GAP) IMPACT Program (2024)
Collaboration Network
Top Collaborators
- PRELIMINARY IMPACT OF PATIENT ACTIVATION AND MHEALTH TECHNOLOGY ON HBA1C AND CARDIOVASCULAR RISK IN PATIENTS WITH DIABETES MELLITUS: THE OFFICE GUIDELINES APPLIED TO PRACTICE - IMPACT PROGRAM
- Abstract P332: High Shared Decision-Making Scores Associated with Blood Pressure Control: The Office Guidelines Applied to Practice (Office-GAP) IMPACT Program
- PRELIMINARY IMPACT OF PATIENT ACTIVATION AND MHEALTH TECHNOLOGY ON HBA1C AND CARDIOVASCULAR RISK IN PATIENTS WITH DIABETES MELLITUS: THE OFFICE GUIDELINES APPLIED TO PRACTICE - IMPACT PROGRAM
- Abstract P332: High Shared Decision-Making Scores Associated with Blood Pressure Control: The Office Guidelines Applied to Practice (Office-GAP) IMPACT Program
- PRELIMINARY IMPACT OF PATIENT ACTIVATION AND MHEALTH TECHNOLOGY ON HBA1C AND CARDIOVASCULAR RISK IN PATIENTS WITH DIABETES MELLITUS: THE OFFICE GUIDELINES APPLIED TO PRACTICE - IMPACT PROGRAM
- Abstract P332: High Shared Decision-Making Scores Associated with Blood Pressure Control: The Office Guidelines Applied to Practice (Office-GAP) IMPACT Program
- Same day discharge after structural heart disease interventions in the era of the coronavirus-19 pandemic and beyond
- Same day discharge after structural heart disease interventions in the era of the coronavirus-19 pandemic and beyond
- Same day discharge after structural heart disease interventions in the era of the coronavirus-19 pandemic and beyond
- Same day discharge after structural heart disease interventions in the era of the coronavirus-19 pandemic and beyond
- Same day discharge after structural heart disease interventions in the era of the coronavirus-19 pandemic and beyond
- Same day discharge after structural heart disease interventions in the era of the coronavirus-19 pandemic and beyond
- PRELIMINARY IMPACT OF PATIENT ACTIVATION AND MHEALTH TECHNOLOGY ON HBA1C AND CARDIOVASCULAR RISK IN PATIENTS WITH DIABETES MELLITUS: THE OFFICE GUIDELINES APPLIED TO PRACTICE - IMPACT PROGRAM
- PRELIMINARY IMPACT OF PATIENT ACTIVATION AND MHEALTH TECHNOLOGY ON HBA1C AND CARDIOVASCULAR RISK IN PATIENTS WITH DIABETES MELLITUS: THE OFFICE GUIDELINES APPLIED TO PRACTICE - IMPACT PROGRAM
- PRELIMINARY IMPACT OF PATIENT ACTIVATION AND MHEALTH TECHNOLOGY ON HBA1C AND CARDIOVASCULAR RISK IN PATIENTS WITH DIABETES MELLITUS: THE OFFICE GUIDELINES APPLIED TO PRACTICE - IMPACT PROGRAM
- Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities
- Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities
- Diabetic foot ulcer: A comprehensive review of pathophysiology and management modalities
Similar Researchers
Based on overlapping research topics